MaxSimil

MaxSimil is a patented, monoglyceride-rich fish oil (MRFO) technology designed to enhance the absorption of omega-3 fatty acids. Developed by Ingredia, the technology employs a proprietary enzymatic process that mimics human digestion by converting standard fish oil triglycerides into monoglycerides. This "pre-digested" form allows for direct absorption into the intestinal tract without the prerequisite of emulsification by bile salts or breakdown by pancreatic lipase. Consequently, MaxSimil demonstrates significantly higher bioavailability of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) compared to traditional ethyl ester or triglyceride forms, making it particularly beneficial for individuals with digestive sensitivities or malabsorption syndromes. It is marketed as a premium nutraceutical ingredient for cardiovascular support, cognitive health, and inflammatory modulation.

Brand names

MaxSimilOmegaMonoPure

Other names

Monoglyceride-rich fish oilMRFO